Loading provider…
Loading provider…
Ophthalmology Physician in Rancho Cordova, CA
NPI: 1063439776Primary Practice Location
Martel Eye Medical Group
11216 Trinity River Dr, Rancho Cordova, CA
Primary Employer
Martel Eye Medical Group
martelmd.com
HQ Phone
Get MD Joseph's Phone NumberMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1982 - 2026
CO State Medical License
1980 - 1987

American Board of Ophthalmology
Ophthalmology
University of Wisconsin–Madison
med.wisc.edu
Medical School
Until 1978
University of Colorado
Residency • Ophthalmology
1979 - 1982
San Joaquin General Hospital
Internship • Internal Medicine
1978 - 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 221 | 243 |
| 2 | 92250Photography of the retina | 183 | 203 |
| 3 | 76519Ultrasound of eye for determination of lens power | 168 | 191 |
| 4 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 152 | 166 |
| 5 | 66984Removal of cataract with insertion of lens | 102 | 111 |
'OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain
Authors: Michael Korenfeld, Joe Gira, Tom Walters, Dale Usner, Eric Donnenfeld, Kevin
Publication Date: 2022-12
Authors: John Goosey, Joseph Martel, Sherif El-Harazi, William Lipsky, David Wirta
Journal: BMC Ophthalmol
Publication Date: 2024-07-17
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: 0.02% Betamethasone Sodium Phosphate, DRUG: 0.04% Betamethasone Sodium Phosphate
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension